Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes

BACKGROUND: Berberine is an isoquinoline alkaloid widely used to improve the glucidic and lipidic profiles of patients with hypercholesterolemia, metabolic syndrome, and type 2 diabetes. The limitation of berberine seems to be its poor oral bioavailability, which is affected by the presence, in ente...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Di Pierro, Francesco, Putignano, Pietro, Villanova, Nicola, Montesi, Luca, Moscatiello, Simona, Marchesini, Giulio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2013
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3838471/
https://ncbi.nlm.nih.gov/pubmed/24277991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S54308
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia